E W Larson

679 total citations
17 papers, 497 citations indexed

About

E W Larson is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, E W Larson has authored 17 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Molecular Biology. Recurrent topics in E W Larson's work include Inhalation and Respiratory Drug Delivery (4 papers), Vector-borne infectious diseases (3 papers) and Respiratory viral infections research (2 papers). E W Larson is often cited by papers focused on Inhalation and Respiratory Drug Delivery (4 papers), Vector-borne infectious diseases (3 papers) and Respiratory viral infections research (2 papers). E W Larson collaborates with scholars based in United States, Sweden and Germany. E W Larson's co-authors include Joseph W. Dominik, R A Kishimoto, Ε. H. Stephenson, Harry Rozmiarek, M. D. Kastello, John D. White, Kenneth Hedlund, Virginia McGann, Carl E. Pedersen and T. W. Slone and has published in prestigious journals such as Applied and Environmental Microbiology, JNCI Journal of the National Cancer Institute and Journal of Clinical Microbiology.

In The Last Decade

E W Larson

17 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E W Larson United States	13	196	130	100	95	91	17	497
Moulton Je Zimbabwe	14	96 0.5×	119 0.9×	70 0.7×	44 0.5×	48 0.5×	38	413
Crawford Tb	9	86 0.4×	133 1.0×	24 0.2×	120 1.3×	54 0.6×	11	509
C S Callaway United States	11	244 1.2×	126 1.0×	105 1.1×	217 2.3×	31 0.3×	17	682
S. Peacock United States	11	154 0.8×	109 0.8×	21 0.2×	33 0.3×	73 0.8×	14	532
M Thibon France	13	84 0.4×	238 1.8×	112 1.1×	76 0.8×	110 1.2×	24	512
T. Nikkilä Sweden	11	138 0.7×	93 0.7×	61 0.6×	152 1.6×	163 1.8×	17	470
Yves Girerd-Chambaz France	12	249 1.3×	112 0.9×	68 0.7×	131 1.4×	264 2.9×	21	568
Gut W Poland	9	234 1.2×	120 0.9×	113 1.1×	91 1.0×	108 1.2×	47	452
Perryman Le United States	11	68 0.3×	71 0.5×	53 0.5×	174 1.8×	27 0.3×	19	400
R. O. Spertzel United States	13	322 1.6×	174 1.3×	22 0.2×	94 1.0×	239 2.6×	31	576

Countries citing papers authored by E W Larson

Since Specialization

Citations

This map shows the geographic impact of E W Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E W Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E W Larson more than expected).

Fields of papers citing papers by E W Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E W Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E W Larson. The network helps show where E W Larson may publish in the future.

Co-authorship network of co-authors of E W Larson

This figure shows the co-authorship network connecting the top 25 collaborators of E W Larson. A scholar is included among the top collaborators of E W Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E W Larson. E W Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Heras, M. De las, Sanford H. Barsky, P S Hasleton, et al.. (2000). Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. European Respiratory Journal. 16(2). 330–330. 53 indexed citations

Stephenson, Ε. H., E W Larson, & Joseph W. Dominik. (1984). Effect of environmental factors on aerosol‐induced lassa virus infection. Journal of Medical Virology. 14(4). 295–303. 101 indexed citations

Kishimoto, R A, Janet C. Gonder, James W. Johnson, John A. Reynolds, & E W Larson. (1981). Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).. PubMed. 31(1). 48–51. 10 indexed citations

Kishimoto, R A, John D. White, Virginia McGann, et al.. (1981). In vitro responses of guinea pig peritoneal macrophages to Legionella pneumophila. Infection and Immunity. 31(3). 1209–1213. 49 indexed citations

Larson, E W, Joseph W. Dominik, & T. W. Slone. (1980). Aerosol stability and respiratory infectivity of japanese B encephalitis virus. Infection and Immunity. 30(2). 397–401. 26 indexed citations

Kishimoto, R A, M. D. Kastello, John D. White, et al.. (1979). In vitro interaction between normal cynolmolgus monkey alveolar macrophages and Legionnaires disease bacteria. Infection and Immunity. 25(2). 761–763. 38 indexed citations

Gonder, Janet C., R A Kishimoto, M. D. Kastello, Carl E. Pedersen, & E W Larson. (1979). Cynomolgus Monkey Model for Experimental Q Fever Infection. The Journal of Infectious Diseases. 139(2). 191–196. 33 indexed citations

Wilson, S Z, Vernon Knight, Robert H. Moore, & E W Larson. (1979). Amantadine Small-Particle Aerosol: Generation and Delivery to Man. Experimental Biology and Medicine. 161(3). 350–354. 15 indexed citations

Kishimoto, R A, James W. Johnson, R H Kenyon, et al.. (1978). Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infection and Immunity. 19(1). 194–198. 21 indexed citations

10.

Kishimoto, R A, Harry Rozmiarek, & E W Larson. (1978). Experimental Q fever infection in congenitally athymic nude mice. Infection and Immunity. 22(1). 69–71. 45 indexed citations

11.

Dominik, Joseph W., et al.. (1977). Continuous aerosol therapy system using a modified Collison nebulizer. Journal of Clinical Microbiology. 5(2). 131–136. 13 indexed citations

12.

Larson, E W, et al.. (1976). Influenza virus population dynamics in the respiratory tract of experimentally infected mice. Infection and Immunity. 13(2). 438–447. 51 indexed citations

13.

Larson, E W, E. L. Stephen, & J. S. Walker. (1976). Therapeutic Effects of Small-Particle Aerosols of Ribavirin on Parainfluenza (Sendai) Virus Infections of Mice. Antimicrobial Agents and Chemotherapy. 10(4). 770–772. 13 indexed citations

14.

Larson, E W, et al.. (1976). Aerosol Evaluations of the De Vilbiss No. 40 and Vaponefrin Nebulizers. Applied and Environmental Microbiology. 31(1). 150–151. 14 indexed citations

15.

Larson, E W, et al.. (1974). Modified Spinning Top Homogeneous Spray Apparatus for Use in Experimental Respiratory Disease Studies. Applied Microbiology. 28(6). 929–934. 10 indexed citations

16.

Larson, E W, et al.. (1974). Modified Spinning Top Homogeneous Spray Apparatus for Use in Experimental Respiratory Disease Studies. Applied Microbiology. 28(6). 929–934. 3 indexed citations

17.

Larson, E W, et al.. (1970). Investigations of Survival Properties of Airborne Murine Leukemia Virus<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 44(4). 937–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact